or Try an Advanced Search...

    Technical Analysis for MYNZ - Mainz Biomed B.V.

    Grade Last Price % Change Price Change
    F 0.21 -7.32% -0.02
    MYNZ closed up 2.0 percent on Wednesday, November 20, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical MYNZ trend table...
    Date Alert Name Type % Chg
    Bullish Engulfing Bullish -7.32%
    Bollinger Band Squeeze Range Contraction -7.32%
    Calm After Storm Range Contraction -7.32%
    BB Squeeze + Lower Band Touch Range Contraction -7.32%
    BB Squeeze Started Range Contraction -7.32%
    Outside Day Range Expansion -7.32%
    Wide Bands Range Expansion -7.32%
    Lower Bollinger Band Touch Weakness -7.32%
    Oversold Stochastic Weakness -7.32%
    MACD Bearish Signal Line Cross Bearish -5.46%
    Older End-of-Day Signals for MYNZ ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low 15 minutes ago
    Lower Bollinger Band Support 15 minutes ago
    Down 10% 15 minutes ago
    60 Minute Opening Range Breakdown about 1 hour ago
    1.5x Volume Pace about 3 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    MYNZ Chart by TradingView
    Basic chart:

    Profile

    Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, an early-stage molecular lateral-flow test; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Cancer Clinical Medicine Medical Genetics Medical Test Pancreatic Cancer Colorectal Cancer Molecular Diagnostics Diagnostic Tests Cancer Screening Innogenetics

    Is MYNZ a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 The Oncology Bet Is Already Paying Off For Pfizer
    Nov 12 Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
    Oct 22 Mainz Biomed restructured operations, implemented cost reductions
    Oct 21 Mainz Biomed B.V. GAAP EPS of -$0.49, revenue of $520.77M
    Oct 21 Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
    Oct 10 Mainz Biomed Secures Additional $1.5M Funding
    Oct 8 Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version
    Oct 1 The Covid Era Tech Promises To Reinvent Cancer Treatment
    Oct 1 Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
    Sep 20 Pfizer Advances On Its Cancer Journey
    See more MYNZ news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.79
    52 Week Low 0.1852
    Average Volume 3,556,595
    200-Day Moving Average 0.58
    50-Day Moving Average 0.26
    20-Day Moving Average 0.24
    10-Day Moving Average 0.24
    Average True Range 0.04
    RSI (14) 42.86
    ADX 18.92
    +DI 22.20
    -DI 17.17
    Chandelier Exit (Long, 3 ATRs) 0.25
    Chandelier Exit (Short, 3 ATRs) 0.31
    Upper Bollinger Bands 0.28
    Lower Bollinger Band 0.20
    Percent B (%b) 0.26
    BandWidth 31.40
    MACD Line -0.01
    MACD Signal Line -0.01
    MACD Histogram -0.0004
    Fundamentals Value
    Market Cap 4.56 Million
    Num Shares 20.4 Million
    EPS -1.92
    Price-to-Earnings (P/E) Ratio -0.12
    Price-to-Sales 24.92
    Price-to-Book 6.79
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.26
    Resistance 3 (R3) 0.26 0.24 0.26
    Resistance 2 (R2) 0.24 0.23 0.25 0.26
    Resistance 1 (R1) 0.23 0.23 0.24 0.24 0.25
    Pivot Point 0.22 0.22 0.22 0.22 0.22
    Support 1 (S1) 0.21 0.21 0.21 0.21 0.20
    Support 2 (S2) 0.19 0.20 0.19 0.19
    Support 3 (S3) 0.18 0.19 0.19
    Support 4 (S4) 0.18